Malignant Glioma
📧 Sign up to get email alerts when something new happens for Malignant Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2010-09-24Clinical Trial Update: Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas [Phase 1, Phase 2]
The Phase 1/2 clinical trial evaluating immunotoxin therapy for children with recurrent malignant gliomas has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2010-07-16Clinical Trial Update: Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors [Phase 2]
Phase 2 clinical trial evaluating panobinostat (LBH589) for recurrent malignant gliomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating high-dose irinotecan (CPT-11) in patients with recurrent unresectable malignant glioma has been comple…
-
CLINICAL_TRIALS research · 2009-10-16Clinical Trial Update: Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma [Phase 1]
Phase 1 trial evaluating Carmustine implants with O6-benzylguanine in children with recurrent malignant glioma. The study status is terminat…
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma. [Phase 1, Phase 2]
An early Phase 1/2 clinical trial evaluating the drug Gimatecan in adults with malignant glioma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-04-09Clinical Trial Update: Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma [Phase 1]
Phase I trial evaluating arsenic trioxide in combination with stereotactic radiotherapy for recurrent malignant glioma has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Brachytherapy in Treating Patients With Recurrent Malignant Glioma [Phase 1]
A Phase 1 clinical trial evaluating brachytherapy for recurrent malignant glioma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Carmustine in Treating Patients With Recurrent Malignant Glioma [Phase 1]
This Phase 1 trial update reports results for Carmustine in patients with recurrent malignant glioma.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma [Phase 1]
Phase 1 trial evaluating O6-Benzylguanine with Carmustine implants for recurrent malignant glioma has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-13Clinical Trial Update: Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas [Phase 1]
The document reports the completion of a Phase 1 clinical trial evaluating alanosine in patients with progressive or recurrent malignant gli…
-
CLINICAL_TRIALS trial_result · 2009-01-13Clinical Trial Update: Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating atrasentan for patients with progressive or recurrent malignant …
-
CLINICAL_TRIALS trial_result · 2008-12-16Clinical Trial Update: G207 Followed by Radiation Therapy in Malignant Glioma [Phase 1]
A Phase 1 trial evaluating G207 followed by radiation therapy for malignant glioma has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-11Clinical Trial Update: Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas [Phase 2]
Phase 2 trial evaluating the combination of cetuximab, bevacizumab, and irinotecan in patients with malignant glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-24Clinical Trial Update: Karenitecin in Treating Patients With Recurrent Malignant Glioma [Phase 1]
A Phase 1 study evaluating Karenitecin in patients with recurrent malignant glioma has completed.
-
CLINICAL_TRIALS research · 2007-10-31Clinical Trial Update: Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma [Phase 2]
Phase 2 clinical trial evaluating radiation with concomitant and sequential temozolomide for newly diagnosed supratentorial malignant glioma…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Study of LY317615 in Patients With Brain Tumors [Phase 2]
Phase 2 clinical trial of LY317615 in patients with malignant glioma has completed.
-
FDA approval · 2006-12-26FDA Approved: GLIADEL — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for GLIADEL (carmustine) by Azurity Pharmaceuticals, Inc.